Immunization by inoculation of DNA transcription unit
View Patent ↗This invention relates to a method of immunizing a vertebrate, comprising introducing into the vertebrate a DNA transcription unit which comprises DNA encoding a desired antigen or antigens. The uptake of the DNA transcription unit by a host vertebrate results in the expression of the desired antigen or antigens, thereby eliciting humoral or cell-mediated immune responses or both humoral and cell-mediated responses. The elicited humoral and cell-mediated immune response can provide protection against infection by pathogenic agents, provide an anti-tumor response, or provide contraception. The host can be any vertebrate, avian or mammal, including humans.
1. A method of immunizing a vertebrate against an H1N1 influenza virus infection, said method comprising administering parenterally to the vertebrate, prior to infection by an H1N1 influenza virus, a plurality of the same plasmid vectors comprising DNA encoding an H1N1 influenza virus antigen operatively linked to a cytomegalovirus (CMV) promoter, wherein the plasmid vectors are administered with a gene gun, thereby eliciting a protective immune response comprising both a humoral and a cell-mediated immune response against the antigen, whereby the vertebrate is protected from disease caused by a subsequent infection by the H1N1 influenza virus, wherein the plasmid vectors are affixed to gold particles, and wherein an amount equivalent to 0.04 μg to 0.4 μg of the plasmid vectors that would be administered to a mouse is administered to the vertebrate.
2. The method of claim 1 , wherein the plasmid vectors are administered to the epidermis of the vertebrate.
3. The method of claim 1 , wherein the antigen is an H1N1 influenza virus hemagglutinin.
4. The method of claim 1 , wherein the vertebrate is a mammal.
5. The method of claim 4 , wherein the mammal is a human.
6. The method of claim 1 , wherein the H1N1 influenza antigen comprises type H1 hemagglutinin, and wherein the promoter comprises a cytomegalovirus immediate early promoter.
7. The method of claim 1 , wherein an amount equivalent to 0.4 μg of the plasmid vectors that would be administered to a mouse is administered to the vertebrate.